Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series

Karthik Gnanapandithan, MD MS, Prakash Kharel, MD, Alyssa Grimshaw, MSLIS, Smith Giri, MBBS

Blood (2019) 134 (Supplement_1): 3606.

https://doi.org/10.1182/blood-2019-132203

Published: 2019

Journal Articles

A Single Institution Experience of Bortezomib for Gvhd in a Pediatric HSCT Population

Devangi Shah, Jennifer Reichbach Douglas, DNP, APRN, CPHON, Jumana Ashy, Gregory Suhrheinrich, Edward Dela Ziga, MD, Asha B. Pillai, MD, Julio C Barredo, MD, Warren Alperstein, MD

Blood (2019) 134 (Supplement_1): 5680.

https://doi.org/10.1182/blood-2019-125884

Published: 2019

Journal Articles

Spectrum of Neurologic Complications after Allogeneic Hematopoietic Cell Transplantation for Hematologic Diseases in Adults: Systematic Review and Meta-Analysis

Maria Gavriilaki, MD, Maria Mainou, MD, Eleni Gavriilaki, MD, Anna-Bettina Haidich, Sotirios Papagiannopoulos, Ioanna Sakellari, Achilles Anagnostopoulos, Vasilis Kimiskidis

Blood (2019) 134 (Supplement_1): 5692.

https://doi.org/10.1182/blood-2019-128641

Published: 2019

Journal Articles

Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation

Blood (2018) 132 (Supplement 1): 2181.

https://doi.org/10.1182/blood-2018-99-115467

Published: 2018

Journal Articles

Association of Risk of Incident and Recurrent Venous Thromboembolism with Oral Glucocorticoid Treatment

Fernanda Andrade Orsi, MD, Willem M Lijfering, MD, Geert-Jan Geersing, MD, Frits Richard Rosendaal, MD, Olaf Dekkers, MD, Saskia le Cessie, PhD, Suzanne Cannegieter, MD

Blood (2018) 132 (Supplement 1): 420.

https://doi.org/10.1182/blood-2018-99-115112

Published: 2018

Journal Articles

Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review

Laura Spatafora, Breanne Golemiec, Lehana Thabane, PhD, Laura Banfield, Christopher M. Hillis, MD, Constantine Samaan, MD, Uma Athale, MD MBBS,MSc

Blood (2018) 132 (Supplement 1): 4273.

https://doi.org/10.1182/blood-2018-99-117464

Published: 2018

Journal Articles

Severe Ocular Graft-Versus-Host Disease Successfully Treated with Amniotic Membrane Transplantation - Case Series

Zinaida Peric, MD PhD, Ivan Skegro, MD, Nadira Durakovic, MD, Lana Desnica, MD PhD, Ranka Serventi-Seiwerth, MD, Drazen Pulanic, MD PhD, Igor Petricek, MD PhD, Steven Z. Pavletic, MD, Radovan Vrhovac, MD PhD

Blood (2017) 130 (Supplement 1): 3270.

https://doi.org/10.1182/blood.V130.Suppl_1.3270.3270

Published: 2017

Journal Articles

Effect of Pregnancy on the Clinical Course of ITP Pregnant Women and Their Newborns. Resuts of a Spanish Case Series of 297 Primary ITP Pregnancies

Blood (2017) 130 (Supplement 1): 4847.

https://doi.org/10.1182/blood.V130.Suppl_1.4847.4847

Published: 2017

Journal Articles

Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status

Blood (2017) 130 (Supplement 1): 4248.

https://doi.org/10.1182/blood.V130.Suppl_1.4248.4248

Published: 2017

Journal Articles

Therapy for Children and Adults with EGIL- or WHO2008-Defined Mixed Phenotype Acute Leukemia: A Systematic Review and Meta-Analysis

Maria A Maruffi, MD, Richard Sposto, PhD, Matthew J Oberley, MDPhD, Lynn Kysh, Etan Orgel, MD MS

Blood (2017) 130 (Supplement 1): 2609.

https://doi.org/10.1182/blood.V130.Suppl_1.2609.2609

Published: 2017

Journal Articles

Mast Cell Leukemia: Clinical Heterogeneity, Molecular Aberrations, Treatment Responses, Survival, and Prognostic Factors

Mohamad Jawhar, MD, Juliana Schwaab, MD, Manja Meggendorfer, PhD, Nicole Naumann, Hans-Peter Horny, MD, Karl Sotlar, MD, Torsten Haferlach, MD, Karla Schmitt, MD, Alice Fabarius, PhD, Peter Valent, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Georgia Metzgeroth, MD, Andreas Reiter, MD

Blood (2016) 128 (22): 3109.

https://doi.org/10.1182/blood.V128.22.3109.3109

Published: 2016

Journal Articles

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

Sumita Ratnasingam, MBBS, Patricia A. Walker, MBBS, Huy Tran, MBBS, Zane Kaplan, MD, James David McFadyen, MD, Huyen Tran, MD, Tse-Chieh Teh, MD, Erica M. Wood, MD, John V. Catalano, MD, Stephen Opat, MBBS, Jake Shortt, MD

Blood (2015) 126 (23): 3457.

https://doi.org/10.1182/blood.V126.23.3457.3457

Published: 2015

Journal Articles

Reduced Relapse Risk in Acute Myelogenous Leukemia (AML) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients Who Experienced CMV Reactivation: Influence of Donor KIR Genotypes

Anthony Stein, Ketevan Gendzekhadze, PhD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS MPH, Sandra H. Thomas, PhD, Stephen J. Forman, John A. Zaia, MD, David Senitzer, PhD, Ryotaro Nakamura, MD

Blood (2014) 124 (21): 669.

https://doi.org/10.1182/blood.V124.21.669.669

Published: 2014

Journal Articles

NK Cell Recovery and Costimulatory Molecule Profiles after Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM) Patients

Myo Htut, MD, Ghislaine Gallez-Hawkins, Joycelynne Palmer, PhD, Laetitia Jeannet, Leanne Goldstein, Andy Dagis, Ricardo Spielberger, MD, Pablo Miguel Parker, Len Farol, MD, Firoozeh Sahebi, MD, Chatchada Karanes, MD, Stephen J. Forman, Amrita Krishnan, MD, John A. Zaia, MD

Blood (2014) 124 (21): 2039.

https://doi.org/10.1182/blood.V124.21.2039.2039

Published: 2014

Journal Articles

Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT

Robert Chen, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS MPH, Sandra H. Thomas, PhD, Tanya Paris, Leslie Popplewell, MD, Chatchada Karanes, MD, Tanya Siddiqi, MD, Auayporn Nademanee, MD, Ji-Lian Cai, MD, Stephen J. Forman, MD

Blood (2013) 122 (21): 3374.

https://doi.org/10.1182/blood.V122.21.3374.3374

Published: 2013

Journal Articles

Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL

Robert W. Chen, MD, Joycelynne Palmer, PhD, Tanya Siddiqi, MD, Sandra H. Thomas, PhD, Young Kim, MD, Chen T Binhong, MD, Amrita Krishnan, MD, Nitya Nathwani, MD, Ji-Lian Cai, MD, PhD, Michelle Mott, RN, Deron Matsuoka, BS, Stephen J Forman, MD

Blood (2012) 120 (21): 3699.

https://doi.org/10.1182/blood.V120.21.3699.3699

Published: 2012

Journal Articles

A Systematic Review on the Use of Intrathecal Rituximab in CNS Lymphoma

Ahraaz Wyne, MD, Leslie Skeith, MD, Joy E. Mangel, MD, FRCPC, Anargyros Xenocostas, MD, FRCPC, Alejandro Lazo-Langner, MD, MSc

Blood (2011) 118 (21): 4987.

https://doi.org/10.1182/blood.V118.21.4987.4987

Published: 2011

Journal Articles

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Joyce Collins, PhD, Margaret O'Donnell, M.D., F.R.C.P.C., Anthony Selwyn Stein, M.D., Ricardo Spielberger, MD, Stephen Forman, MD

Blood (2010) 116 (21): 3467.

https://doi.org/10.1182/blood.V116.21.3467.3467

Published: 2010

Journal Articles

Safety and Efficacy Profile of rAHF-PFM for Immune Tolerance Induction as Assessed In 3 Clinical Trials (PUP ITI, PRE-PAIR, and PAIR).

Gerald Spotts, PhD, Brigitt E. Abbuehl, MD, Huong D. Luu, PharmD, Clara K. Song, PharmD, Jacqueline A. Dyck-Jones, Norma Guzman-Becerra, LieLing Wu, MyungShin Oh, Michael Zoerer, Judith Jill V. Sosa, Darby E. Stephens, Linda J. Yamamoto, MD, Bruce M. Ewenstein, MD, PhD

Blood (2010) 116 (21): 3670.

https://doi.org/10.1182/blood.V116.21.3670.3670

Published: 2010

Journal Articles

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.

Ryotaro Nakamura, MD, Joycelynne Palmer, Pablo Parker, Anthony Stein, Tracey Stiller, Vinod Pullarkat, David S. Snyder, MD, Ji-Lian Cai, MD, PhD, Shirong Wang, MD, MPH, David Senitzer, PhD, Karen L. Chang, Ravi Bhatia, Stephen J Forman, MD, Margaret O'Donnell, MD

Blood (2009) 114 (22): 2771.

https://doi.org/10.1182/blood.V114.22.2771.2771

Published: 2009

NARROW

Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series

A Single Institution Experience of Bortezomib for Gvhd in a Pediatric HSCT Population

Spectrum of Neurologic Complications after Allogeneic Hematopoietic Cell Transplantation for Hematologic Diseases in Adults: Systematic Review and Meta-Analysis

Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation

Association of Risk of Incident and Recurrent Venous Thromboembolism with Oral Glucocorticoid Treatment

Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review

Severe Ocular Graft-Versus-Host Disease Successfully Treated with Amniotic Membrane Transplantation - Case Series

Effect of Pregnancy on the Clinical Course of ITP Pregnant Women and Their Newborns. Resuts of a Spanish Case Series of 297 Primary ITP Pregnancies

Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status

Therapy for Children and Adults with EGIL- or WHO2008-Defined Mixed Phenotype Acute Leukemia: A Systematic Review and Meta-Analysis

Mast Cell Leukemia: Clinical Heterogeneity, Molecular Aberrations, Treatment Responses, Survival, and Prognostic Factors

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

Reduced Relapse Risk in Acute Myelogenous Leukemia (AML) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients Who Experienced CMV Reactivation: Influence of Donor KIR Genotypes

NK Cell Recovery and Costimulatory Molecule Profiles after Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM) Patients

Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT

Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL

A Systematic Review on the Use of Intrathecal Rituximab in CNS Lymphoma

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Safety and Efficacy Profile of rAHF-PFM for Immune Tolerance Induction as Assessed In 3 Clinical Trials (PUP ITI, PRE-PAIR, and PAIR).

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only